LucyRx, a Bethesda, MD-based pharmacy benefits manager (PBM), received an investment from LRVHealth.
The amount of the deal, which brought total committed capital to more than $500M, was not disclosed.
The company intends to use the funds to accelerate:
- the expansion of its technology-driven PBM model, delivering cost efficiency, personalized support, and plan flexibility.
- the customizable solutions that support formulary management, reduce administrative complexity, and improve medication adherence—while driving down overall costs.
- the analytics and AI-powered tools through LucyIQ, enabling better decision-making for plan sponsors and members.
Led by David Blair, CEO, LucyRx is an independent pharmacy benefit manager (PBM) redefining prescription care. It delivers better outcomes through its integrated specialty network, formulary marketplace, and next-day home delivery solutions. Emowered by its proprietary AI platform, LucyIQ, the company provides real-time insights that support evidence-based clinical decisions, clear pricing, and service from U.S.-based pharmacy technicians.
Partnering with more than 60,000 pharmacies, LucyRx serves over 1,200 clients nationwide.
FinSMEs
16/04/2025